Suppr超能文献

非洛地平与安慰剂相比的降压效果。

Antihypertensive effects of felodipine compared with placebo.

作者信息

Elmfeldt D, Hedner T

出版信息

Drugs. 1985;29 Suppl 2:109-16. doi: 10.2165/00003495-198500292-00020.

Abstract

The effects of felodipine and placebo on blood pressure, heart rate and tolerability were investigated in 4 different groups of patients. One group had not received previous therapy, whereas the other 3 groups received concomitant antihypertensive compounds (beta-blockers, diuretics or beta-blocker + diuretics). The haemodynamic effects and tolerability were studied after a single dose, as well as during steady-state conditions. After a single dose of felodipine there was a rapid and significant decrease in blood pressure and increase in heart rate with felodipine alone as well as with combination therapy. During long term treatment, blood pressure was significantly decreased after felodipine during the dosing interval (12h), irrespective of concomitant treatment. Heart rate, however, was not increased, even in patients without a beta-blocker. The reduction in blood pressure was correlated with the plasma concentration of felodipine after single-dose administration, but not during long term treatment. Felodipine was generally well tolerated. In the short term, headache was the most common side effect, while swelling of the ankles was the most frequent adverse effect during long term treatment. In conclusion, felodipine is a promising antihypertensive compound, which may be used in the treatment of high blood pressure, either alone or in combination with other agents.

摘要

在4组不同患者中研究了非洛地平与安慰剂对血压、心率及耐受性的影响。一组患者此前未接受过治疗,而其他3组患者正在接受联合抗高血压药物治疗(β受体阻滞剂、利尿剂或β受体阻滞剂+利尿剂)。研究了单剂量给药后以及稳态条件下的血流动力学效应和耐受性。单剂量服用非洛地平后,无论是单独使用非洛地平还是联合治疗,血压均迅速显著下降,心率增加。在长期治疗期间,无论联合治疗情况如何,给药间隔(12小时)内服用非洛地平后血压均显著下降。然而,即使是未服用β受体阻滞剂的患者,心率也未增加。单剂量给药后血压降低与非洛地平血浆浓度相关,但长期治疗期间并非如此。非洛地平总体耐受性良好。短期内,头痛是最常见的副作用,而长期治疗期间脚踝肿胀是最常见的不良反应。总之,非洛地平是一种有前景的抗高血压药物,可单独或与其他药物联合用于治疗高血压。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验